» Articles » PMID: 20455765

Alcohol Use Accelerates HIV Disease Progression

Overview
Publisher Mary Ann Liebert
Date 2010 May 12
PMID 20455765
Citations 161
Authors
Affiliations
Soon will be listed here.
Abstract

The effects of alcohol abuse on HIV disease progression have not been definitively established. A prospective, 30-month, longitudinal study of 231 HIV(+) adults included history of alcohol and illicit drug use, adherence to antiretroviral therapy (ART), CD4(+) cell count, and HIV viral load every 6 months. Frequent alcohol users (two or more drinks daily) were 2.91 times (95% CI: 1.23-6.85, p = 0.015) more likely to present a decline of CD4 to <or=200 cells/microl, independent of baseline CD4(+) cell count and HIV viral load, antiretroviral use over time, time since HIV diagnosis, age, and gender. Frequent alcohol users who were not on ART also increased their risk for CD4 cell decline to <or=200 cells/mm(3) (HR = 7.76: 95% CI: 1.2-49.2, p = 0.03). Combined frequent alcohol use with crack-cocaine showed a significant risk of CD4(+) cell decline (HR = 3.57: 95% CI: 1.24-10.31, p = 0.018). Frequent alcohol intake was associated with higher viral load over time (beta = 0.259, p = 0.038). This significance was maintained in those receiving ART (beta = 0.384, p = 0.0457), but not in those without ART. Frequent alcohol intake and the combination of frequent alcohol and crack-cocaine accelerate HIV disease progression. The effect of alcohol on CD4(+) cell decline appears to be independent of ART, through a direct action on CD4 cells, although alcohol and substance abuse may lead to unmeasured behaviors that promote HIV disease progression. The effect of alcohol abuse on viral load, however, appears to be through reduced adherence to ART.

Citing Articles

Alcohol use and optimal chronic diseases' treatment outcomes among adults aged 40 years and above in rural South Africa.

Mupfuti R, Kabudula C, Francis J Sci Rep. 2025; 15(1):7951.

PMID: 40055425 PMC: 11889103. DOI: 10.1038/s41598-025-91704-7.


Prevalence and factors associated with alcohol use disorders among people living with HIV attending care and treatment centers at Kilimanjaro, Tanzania: A cross-sectional study.

Ghaimo F, Steven Mzilangwe E, Chacha S, Kuganda S PLoS One. 2025; 20(2):e0318120.

PMID: 39899494 PMC: 11790162. DOI: 10.1371/journal.pone.0318120.


Neurological impact of HIV/AIDS and substance use alters brain function and structure.

Haorah J, Malaroviyam S, Iyappan H, Samikkannu T Front Med (Lausanne). 2025; 11:1505440.

PMID: 39839621 PMC: 11747747. DOI: 10.3389/fmed.2024.1505440.


Longitudinal assessments of viral rebound among people with HIV in South Carolina: a population-based cohort study.

Xiao J, Yang X, Ma Y, Olatosi B, Weissman S, Li X AIDS Care. 2024; 37(1):33-42.

PMID: 39374485 PMC: 11698236. DOI: 10.1080/09540121.2024.2411270.


Effects of Alcohol Use on Patient Retention in HIV Care in East Africa.

Monroy A, Goodrich S, Brown S, Balanos T, Bakoyannis G, Diero L AIDS Behav. 2024; 28(12):4020-4028.

PMID: 39225889 PMC: 11586299. DOI: 10.1007/s10461-024-04483-z.


References
1.
Cahill A, Cunningham C, Adachi M, Ishii H, Bailey S, Fromenty B . Effects of alcohol and oxidative stress on liver pathology: the role of the mitochondrion. Alcohol Clin Exp Res. 2002; 26(6):907-15. PMC: 2670542. View

2.
Bautista A . Chronic alcohol intoxication attenuates human immunodeficiency virus-1 glycoprotein 120-induced superoxide anion release by isolated Kupffer cells. Alcohol Clin Exp Res. 1998; 22(2):474-80. View

3.
Baum M, Rafie C, Lai S, Sales S, Page B, Campa A . Crack-cocaine use accelerates HIV disease progression in a cohort of HIV-positive drug users. J Acquir Immune Defic Syndr. 2009; 50(1):93-9. DOI: 10.1097/QAI.0b013e3181900129. View

4.
Mansouri A, Gaou I, de Kerguenec C, Amsellem S, Haouzi D, Berson A . An alcoholic binge causes massive degradation of hepatic mitochondrial DNA in mice. Gastroenterology. 1999; 117(1):181-90. DOI: 10.1016/s0016-5085(99)70566-4. View

5.
Hinkin C, Barclay T, Castellon S, Levine A, Durvasula R, Marion S . Drug use and medication adherence among HIV-1 infected individuals. AIDS Behav. 2006; 11(2):185-94. PMC: 2867605. DOI: 10.1007/s10461-006-9152-0. View